THMO stock led small-cap gains today after the price moved to $0.0001, a one-day change of 9900.00%, on a volume of 331 shares during market hours in the United States (PNK, USD). We look at what drove ThermoGenesis Holdings, Inc. (THMO) higher, how thin liquidity and a small market cap of 1,585 USD shape short-term trading, and why the upcoming earnings notice on 2026-02-25 will matter for momentum. This note gives quick, data-driven context and where analysts and our models see risk and upside.
THMO stock price action and immediate drivers
Today ThermoGenesis (THMO) traded between the day low and high of $0.0001, with a previous close of $0.000001. The reported one-day percent move of 9900.00% reflects a tiny prior price base and very low float dynamics.
Advertisement
Low average volume (396) and shares outstanding of 15,847,517 amplify price moves. Short-interest reporting is now a live data point for traders; see recent MarketBeat coverage for short interest on THMO source
THMO stock fundamentals and financial metrics
ThermoGenesis operates in Healthcare, Medical – Devices, with full-time employees of 25 and a market cap of 1,585 USD. Latest trailing EPS is -3.98, and the company shows negative operating cash flow per share of -1.57.
Key ratios show low liquidity: current ratio 0.44 and cash per share 0.84 USD. Enterprise value is large relative to market cap at 8,557,585 USD, reflecting thin public valuation. These fundamentals explain why valuation swings are volatile and why investors treat THMO as high-risk.
Meyka AI rates THMO with a score out of 100 and technical read
Meyka AI rates THMO with a score out of 100: 62.54 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, industry comparison, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.
On technicals we note RSI 51.85, ADX 64.46 (strong trend signal), and an MFI of 98.70 (overbought). Average trading metrics remain minimal, so technical signals can flip quickly on low volume.
THMO stock catalysts, earnings and risks
The next material date is the earnings announcement on 2026-02-25. With EPS at -3.98 and no positive earnings momentum yet, the report is a potential catalyst for either renewed interest or selling pressure.
Primary risks include thin liquidity, negative operating margins, and working capital deficits (working capital -6,582,000 USD). Short interest and low float can exaggerate moves, and investors should expect high volatility.
THMO stock trading, sector context and liquidity note
ThermoGenesis sits in the Medical – Devices sub-sector of Healthcare, where overall sector performance is steadier than micro-caps. THMO’s trading volume (331) and average (396) show low activity relative to peers.
Because exchange is PNK (United States) and the public float is small, trades can have outsized impact. For traders, position size limits and liquidity checks are essential when handling THMO stock.
THMO stock scenarios, targets and short-term outlook
Scenario planning: bear case $0.00005, base case $0.0001, bull case driven by model catalysts $0.18 (quarterly forecast). These scenarios reflect the stock’s micro-cap structure and the model forecast available.
No broker consensus price target exists publicly. We recommend scenario sizing rather than a single-point target because small changes in supply or interest can create large percentage swings.
Final Thoughts
Key takeaways: THMO stock moved to $0.0001 today on extremely thin trading and a prior very low base, producing a reported change of 9900.00%. ThermoGenesis (THMO, PNK, United States, USD) shows weak cash flow metrics, EPS -3.98, and low liquidity, which together explain volatile price action. Meyka AI’s forecast model projects a quarterly target of $0.18, implying an implied upside of 179,900.00% versus the current price of $0.0001. Forecasts are model-based projections and not guarantees. Given the Meyka AI grade B (62.54) and the upcoming 2026-02-25 earnings, our view is that traders should treat THMO as speculative and size positions accordingly. For recent short-interest context see MarketBeat source and view broader market updates on smaller names source. For Meyka AI real-time data and tools, visit our THMO page for live updates and scans Meyka THMO page.
Advertisement
FAQs
What caused the sharp move in THMO stock today?
The sharp move reflects a tiny prior price base and very low liquidity: price at $0.0001, volume 331, and a small market cap. Low float and short-interest dynamics amplify percentage moves.
How does ThermoGenesis’s financial health affect THMO stock?
ThermoGenesis reports EPS -3.98, negative operating cash flow, and a current ratio 0.44, which increases risk. Weak fundamentals make THMO stock sensitive to news and trading flows.
What is Meyka AI’s view on THMO stock outlook?
Meyka AI grades THMO B (62.54) with a HOLD suggestion. The model projects a quarterly figure of $0.18, but this is model-based and not a guarantee; expect very high volatility.
Should investors trade THMO stock before earnings?
Trading before the 2026-02-25 earnings is speculative. Low volume and thin float can cause sharp swings, so limit position size and use strict risk controls with THMO stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)